COMP <GO>
PASW vs FMFC // EV/EBITDA & P/E VALUATION
Ping An Biomedical Co. Ltd. (Class A) (NASDAQ) VS. Kandal M Venture Limited (Class A) (NASDAQ) • 15-METRIC TALLY: PASW 2
— FMFC 0
■ METRIC PARITY
LAST: $5.00 (-0.20%) • MKT CAP: $15.6M
valuation
—
LAST: $3.80 (+3.83%) • MKT CAP: $1.9M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PASW VS. FMFC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PASW | FMFC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 2.80% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -5.77% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -43.10% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -37.60% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.7 | 27.4 | +24.36 | PASW | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $15.6M | $1.9M | $13.8M | PASW | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PASW REV | FMFC REV | PASW GROSS % | FMFC GROSS % | PASW FCF | FMFC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.8M | — | 2.8% | — | -$902.9K | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PASW // BETA —
FMFC // BETA —